Janet Woodcock, 59, has been appointed director of the Food and Drug Administrations Center for Drug Evaluation and Research, or CDER, according to a news release.
Woodcock, who previously served as CDER director from 1994 to 2005, will immediately assume her duties. They include spearheading pre- and post-market reviews of drugs, as well as directing other activities to ensure the safety and efficacy of prescription and over-the-counter pharmaceuticals. She will also be charged with modernizing the FDAs drug-review system.
An internal medicine specialist and rheumatologist by training, Woodcock has been acting director of CDER since October 2007. She has been an FDA scientist since 1986, and previously served as director of the agencys Office of Therapeutics Research and Review and acting deputy director of the Center for Biologics Evaluation and Research. -- by Shawn Rhea